ImCheck

Imcheck is a France-based biotechnology company that develops and commercializes immunotherapeutic antibodies for the treatment of cancer, infectious and autoimmune diseases.

Business Model:

Revenue: $1.2M

Employees: 11-50

Detailed ImCheck Information

Geographic Data

ImCheck headquarters map

Address: 31 chemin Joseph Aiguier

City: Marseille

State: provence-alpes-côte-d'azur

Zip: 13402

Country: FR

Financial Info

Stage:

series c

Raised Last:

$100M

Raised Total:

$185M

Metrics

3,172,419Website Global Rank

5,084Website Monthly Traffic

Twitter Followers

Description

Imcheck is a France-based biotechnology company that develops and commercializes immunotherapeutic antibodies for the treatment of cancer, infectious and autoimmune diseases.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
8/2019 Grant 1 $2.2M Bpifrance
Bpifrance
9/2020 Series B $0 Pureos Bioventures
Pureos Bioventures
12/2019 Series B $53M Pfizer Ventures
Wellington Partners
Agent Capital
Alexandria Venture Investments
Life Sciences Partners
Gimv
Idinvest Partners
Kurma Partners
Boehringer Ingelheim Venture Fund
10/2017 Venture Round 1 $1.1M Bpifrance
Bpifrance
4/2019 Grant $806.6k
9/2020 Series B $7.1M BB Pureos Bioventures
7/2019 Grant $2.2M Bpifrance
6/2022 Series C $103M Invus
The Leukemia & Lymphoma Society Therapy Acceleration Program
Kurma Partners
Eurazeo
Gimv
Boehringer Ingelheim Venture Fund
Bpifrance
Wellington Partners
Agent Capital
Pureos Bioventures
6/2022 Series C $0 Agent Capital
Alexandria
Andera Partners
Boehringer Ingelheim Venture Fund
Bpifrance
Earlybird Venture Capital
Eurazeo
Gimv
Invus
Kurma Partners
Leukemia &a; Lymphoma Society
EQT life science
Pfizer Venture Investments
Pureos Bioventures
Wellington Partners
Agent Capital
Alexandria
Andera Partners
Boehringer Ingelheim Venture Fund
Bpifrance
Earlybird Venture Capital
Eurazeo
Gimv
Invus
Kurma Partners
Leukemia &a; Lymphoma Society
EQT life science
Pfizer Venture Investments
Pureos Bioventures
Wellington Partners
5/2017 Series A 5 $21.9M Boehringer Ingelheim Venture Fund
Idinvest Partners
Kurma Partners
Gimv
EQT life science
Boehringer Ingelheim Venture Fund
Idinvest Partners
Kurma Partners
12/2019 Series B 11 $53.2M Agent Capital
Alexandria Venture Investments
Boehringer Ingelheim Venture Fund
Bpifrance
Gimv
Idinvest Partners
Kinled Holding
Kurma Partners
Life Sciences Partners
Pfizer Venture Investments
Wellington Partners
Agent Capital
Alexandria Venture Investments
Boehringer Ingelheim Venture Fund
Bpifrance
Gimv
Idinvest Partners
Kinled Holding
Kurma Partners
Life Sciences Partners
Pfizer Venture Investments
Wellington Partners
6/2022 Series C 15 $100M Agent Capital
Alexandria Venture
Andera Partners
Boehringer Ingelheim Venture Fund
Bpifrance
Earlybird Venture Capital
Eurazeo
Gimv
Invus
Kurma Partners
Leukemia &a; Lymphoma Society
Life Sciences Partners
Pfizer Venture Investments
Pureos Bioventures
Wellington Partners
Agent Capital
Alexandria Venture
Andera Partners
Boehringer Ingelheim Venture Fund
Bpifrance
Earlybird Venture Capital
Eurazeo
Gimv
Invus
Kurma Partners
Leukemia &a; Lymphoma Society
Life Sciences Partners
Pfizer Venture Investments
Pureos Bioventures
Wellington Partners
9/2020 Series B 1 $7.1M Pureos Bioventures
Pureos Bioventures
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research